Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Hypothesis: (1) Aripiprazole treatment will be superior to placebo in reducing aggression and
irritability in autistic individuals as shown by reductions in the Aberrant Behavior
Checklist-irritability subscale.
(2) Aripiprazole treatment will be superior to placebo in the acute treatment of global
autism severity.
The purpose of this study is to examine the possible benefit of the medication Aripiprazole
in autistic individuals.
Phase:
N/A
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey